From April 1, 2023 to June 30, 2023, the company has repurchased 6,879,600 shares, representing 1.21% for CNY 39.42 million. With this, the company has completed the repurchase of 14,523,100 shares, representing 2.57% for CNY 79.72 million under the buyback announced on July 15, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.53 CNY | -1.09% | -7.17% | -26.10% |
1st Jan change | Capi. | |
---|---|---|
-26.10% | 353M | |
+42.72% | 748B | |
+34.11% | 598B | |
-5.92% | 356B | |
+18.09% | 325B | |
+4.55% | 283B | |
+17.02% | 245B | |
+9.26% | 211B | |
-4.21% | 209B | |
+2.74% | 166B |
- Stock Market
- Equities
- 600222 Stock
- News Henan Taloph Pharmaceutical Stock Co.,Ltd
- Tranche Update on Henan Taloph Pharmaceutical Stock Co.,Ltd's Equity Buyback Plan announced on July 15, 2022.